In contrast to the pain-free phenotype, there are also debilitating painful Mendelian disorders resulting from gain of function of Nav1.7, such as Inherited Primary Erythromelalgia (IEM), Paroxysmal Extreme Pain Disorder (PEPD) and painful small fibre neuropathy [11–13]. This evidence concerns the gene SCN9A and peripheral neuropathy.